Glycopyrrolate Injection recall: Labeling Error
GLYCOPYRROLATE INJECTION, USP 0.2MG/ML, 1mL VIAL, manufactured by HF Acquisition Co. LLC, Mukilteo, WA 98275, NDC 51662-1487-3
Why was Glycopyrrolate Injection recalled?
Labeling: Label Mix-up
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: 2205095.1, Exp. Date 7/31/2024
- Product
- GLYCOPYRROLATE INJECTION, USP 0.2MG/ML, 1mL VIAL, manufactured by HF Acquisition Co. LLC, Mukilteo, WA 98275, NDC 51662-1487-3
- Recalling firm
- HF Acquisition Co LLC
- Quantity
- 9 boxes of 25 vials
- Distribution
- Distributed in TX, AZ and CA only
- Recall date
- June 14, 2023
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)